Assembly Biosciences (ASMB) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Assembly Biosciences Revenue Highlights


Latest Revenue (Y)

$7.16M

Latest Revenue (Q)

$5.79M

Assembly Biosciences Revenue by Period


Assembly Biosciences Revenue by Year

DateRevenueChange
2023-12-31$7.16M100.00%
2022-12-31--100.00%
2021-12-31$6.25M-92.09%
2020-12-31$79.11M395.55%
2019-12-31$15.96M7.83%
2018-12-31$14.80M64.15%
2017-12-31$9.02M100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Assembly Biosciences generated $7.16M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 48.39% compared to the same period a year ago.

Assembly Biosciences Revenue by Quarter

DateRevenueChange
2024-03-31$5.79M-19.24%
2023-12-31$7.16M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$6.25M100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$1.04M-97.00%
2020-09-30$34.61M-12.10%
2020-06-30$39.38M864.86%
2020-03-31$4.08M-14.37%
2019-12-31$4.77M12.64%
2019-09-30$4.23M37.37%
2019-06-30$3.08M-20.72%
2019-03-31$3.88M4.01%
2018-12-31$3.74M-12.85%
2018-09-30$4.29M33.19%
2018-06-30$3.22M-9.74%
2018-03-31$3.57M7.53%
2017-12-31$3.32M24.66%
2017-09-30$2.66M12.73%
2017-06-30$2.36M244.74%
2017-03-31$684.37K100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31--

Assembly Biosciences generated $5.79M in revenue during Q1 2024, up -19.24% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Assembly Biosciences Revenue Breakdown


Assembly Biosciences Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 18Jun 18
License and Service$1.20M$1.20M

Assembly Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 18: License and Service (100.00%).

Assembly Biosciences Revenue Breakdown by Country

Quarterly Revenue by Country

CountrySep 18Jun 18
License and Service$1.20M$1.20M

Assembly Biosciences's latest quarterly revenue breakdown by geography, as of Sep 18: License and Service (100.00%).

Assembly Biosciences Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$25.11M
SPROSpero Therapeutics$96.73M$10.20M
ASMBAssembly Biosciences$7.16M$5.79M
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$1.44M

ASMB Revenue FAQ


Assembly Biosciences's yearly revenue for 2023 was $7.16M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021. ASMB's yearly revenue for 2021 was $6.25M, representing a decrease of -92.09% compared to 2020.

Assembly Biosciences's quarterly revenue for Q1 2024 was $5.78M, a -19.24% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $7.16M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). ASMB's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

Assembly Biosciences's revenue growth rate for the last 3 years (2021-2023) was 14.53%, and for the last 5 years (2019-2023) was -55.13%.